The purpose of this study was to clarify the role of tumor necrosis factor (TNF) in the recovery from Peritonitis caused by sublethal cecal ligation and puncture (CLP). TNF is thought to play a beneficial role because pretreatment of mice with lipopolysaccharide (LPS) or TNF increased the survival rate of injected animals [1, 2]. To investigate the contribution of endogenous TNF to recovery from Peritonitis we tested the effect of a neutralizing rat anti-mouse TNF monoclonal antibody (Vlq) [3] . We showed that as little as 20 ^g Vlq/mouse effectively prevented lethal shock of the animals caused by subsequent injection of 400 (ig LPS, demonstrating the in vivo efficacy of the antibody. Lethal bolus injections of LPS or bacteria are used as sepsis models by many investigators [4] . In these models the potentially lethal reactions (production of large amounts of interleukin-1 and TNF) of the organism may develop faster than the regulatory inflammatory reactions (e.g., acute-phase proteins, glucocorticoids). Therefore, these models may represent only part of the whole inflammatory repertoire [5]. We preferred CLP as a sepsis model because of its slower development and the presence of a septic focus [6, 7] .
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For sublethal CLP 10-to 14-week-old C3H/HeN mice were anesthetized, and the abdominal skin was shaved. A 0.7-cm midline incision was made. The cecum was exteriorized and filled with feces by milking stool back from the ascending colon. The cecum was ligated below the ileocecal valve and punctured once with a 0.9 x 40 mm needle. Gentie pressure was applied on the ligated cecum to exteriorize a small amount of feces. The cecum was then returned to the peritoneal cavity and the incision closed with clamps and Histoacryl blue (enbucrilate) tissue glue. Mice were observed for at least 2 weeks.
In that TNF is produced and consumed only locally at the punctured cecum. This was in line with findings by other investigators who also did not detect TNF after CLP even when they used lethal CLP or related models [8] . Surviving mice that were killed 2 weeks after CLP showed an encapsulated cecum and strong fibrous adhesions. Examination of mice that had died from CLP after Vlq injection showed no fibrous adhesions to the cecum 1-3 days after CLP. To determine any correlation between the time of declining lethality after Vlq injection and the occurrence of fibrous adhesions treated mice were killed at different times after CLP. There were no adhesions seen after 10 h. After 15 h fibrous adhesions became visible, and after 18 h such adhesions were pronounced (Fig. 2) .
The lethal effect of monoclonal antibody Vlq was prevented by injection of recombinant mouse TNF (rmTNF). Vlq was injected immediately after CLP and rmTNF 1 h later. Remarkably, the same amount of rmTNF that saved CLP mice from lethal Vlq injection killed CLP mice if rmTNF was injected without previous Vlq administration. Therefore, a certain beneficial TNF concentration during CLP-induced Peritonitis may have to be maintained because elimination of endogenous TNF or additional exogenous TNF would be lethal.
These observations may be explained by known properties of TNF. During the early phase of Peritonitis endogenous TNF may stimulate nonlymphoid cells such as granulocytes and macrophages to ingest bacteria. TNF may enhance the procoagulant activity of the endothelium and mesothelium [9] . In addition, TNF may inhibit fibrinolysis [10] . Thus, adhesions of surrounding tissue (omentum, intestines) to the cecum are favoured by TNF. TNF production must be tightly controlled in order to avoid disseminated intravascular coagulation and vascular leakage. One possibility is the control of TNF secretion through Protease inhibitors which may prevent the cleavage of membrane TNF from the cell surface [11] . TNF increases interleukin-6 concentration in the blood, and this cytokine enhances synthesis of acute-phase proteins, some of which are Protease inhibitors [12] . This mechanism may also be effective in other cases in which serum TNF was not detectable but essential for survival because anti-TNF antibodies caused or accelerated the death of the infected animals (e.g. Listeria, bacille Calmette-Guerin, Leishmania) [13, 14, 15, 16] . In summary, these data indicate that the administration of anti-TNF antibodies in sepsis may be deleterious rather than beneficial.
